Safety and Effectiveness of Rivaroxaban and Apixaban compared to warfarin in non-valvular atrial fibrillation patients in the routine clinical practice in the UK (SiERRA UK)

18/02/2019
10/07/2024
EU PAS number:
EUPAS28234
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Study 20343_Study protocol_v1.0_2018-11-12_Redacted

English (997.49 KB - PDF) View document
Study results
Study results

20343_EU-PASS_Abstract_Redacted

English (425.44 KB - PDF) View document
Study report
Study report

SIERRA Study Report SB_27 Sep 2021

English (4.16 MB - PDF) View document
Other information